Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
1,000 35 40 35 40 B-lower_bound
/ 40 41 40 41 I-lower_bound
mm^3 41 45 41 45 I-lower_bound

Agree 0 5 46 51 B-contraception_consent
to 6 8 52 54 I-contraception_consent
practice 9 17 55 63 I-contraception_consent
effective 18 27 64 73 I-contraception_consent
barrier 28 35 74 81 I-contraception_consent
contraception 36 49 82 95 I-contraception_consent
during 50 56 96 102 O
the 57 60 103 106 O
entire 61 67 107 113 O
study 68 73 114 119 B-treatment
treatment 74 83 120 129 I-treatment
period 84 90 130 136 O
and 91 94 137 140 O
through 95 102 141 148 O
90 103 105 149 151 B-upper_bound
days 106 110 152 156 I-upper_bound
after 111 116 157 162 I-upper_bound
the 117 120 163 166 O
last 121 125 167 171 O
dose 126 130 172 176 O
of 131 133 177 179 O
study 134 139 180 185 B-treatment
drug 140 144 186 190 I-treatment

Agree 0 5 191 196 B-contraception_consent
to 6 8 197 199 I-contraception_consent
practice 9 17 200 208 I-contraception_consent
true 18 22 209 213 I-contraception_consent
abstinence 23 33 214 224 I-contraception_consent
when 34 38 225 229 O
this 39 43 230 234 O
is 44 46 235 237 O
in 47 49 238 240 O
line 50 54 241 245 O
with 55 59 246 250 O
the 60 63 251 254 O
preferred 64 73 255 264 O
and 74 77 265 268 O
usual 78 83 269 274 O
lifestyle 84 93 275 284 O
of 94 96 285 287 O
the 97 100 288 291 O
subject 101 108 292 299 O
( 109 110 300 301 O
periodic 110 118 301 309 O
abstinence 119 129 310 320 O
[ 130 131 321 322 O
e.g. 131 135 322 326 O
, 135 136 326 327 O
calendar 137 145 328 336 B-contraception_consent
, 145 146 336 337 O
ovulation 147 156 338 347 B-contraception_consent
, 156 157 347 348 O
symptothermal 158 171 349 362 B-contraception_consent
, 171 172 362 363 O
post 173 177 364 368 B-contraception_consent
- 177 178 368 369 I-contraception_consent
ovulation 178 187 369 378 I-contraception_consent
methods 188 195 379 386 I-contraception_consent
] 195 196 386 387 O
and 197 200 388 391 O
withdrawal 201 211 392 402 O
are 212 215 403 406 O
not 216 219 407 410 O
acceptable 220 230 411 421 O
methods 231 238 422 429 O
of 239 241 430 432 O
contraception 242 255 433 446 O
) 255 256 446 447 O

Agree 0 5 448 453 B-contraception_consent
to 6 8 454 456 I-contraception_consent
practice 9 17 457 465 I-contraception_consent
true 18 22 466 470 I-contraception_consent
abstinence 23 33 471 481 I-contraception_consent
when 34 38 482 486 O
this 39 43 487 491 O
is 44 46 492 494 O
in 47 49 495 497 O
line 50 54 498 502 O
with 55 59 503 507 O
the 60 63 508 511 O
preferred 64 73 512 521 O
and 74 77 522 525 O
usual 78 83 526 531 O
lifestyle 84 93 532 541 O
of 94 96 542 544 O
the 97 100 545 548 O
subject 101 108 549 556 O
; 108 109 556 557 O
( 110 111 558 559 O
periodic 111 119 559 567 O
abstinence 120 130 568 578 O
[ 131 132 579 580 O
e.g. 132 136 580 584 O
, 136 137 584 585 O
calendar 138 146 586 594 O
, 146 147 594 595 O
ovulation 148 157 596 605 O
, 157 158 605 606 O
symptothermal 159 172 607 620 O
, 172 173 620 621 O
post 174 178 622 626 O
- 178 179 626 627 O
ovulation 179 188 627 636 O
methods 189 196 637 644 O
] 196 197 644 645 O
and 198 201 646 649 O
withdrawal 202 212 650 660 O
are 213 216 661 664 O
not 217 220 665 668 O
acceptable 221 231 669 679 O
methods 232 239 680 687 O
of 240 242 688 690 O
contraception 243 256 691 704 O
) 256 257 704 705 O

Alanine 0 7 706 713 B-clinical_variable
aminotransferase 8 24 714 730 I-clinical_variable
( 25 26 731 732 I-clinical_variable
ALT 26 29 732 735 I-clinical_variable
) 29 30 735 736 I-clinical_variable
and 31 34 737 740 O
aspartate 35 44 741 750 B-clinical_variable
aminotransferase 45 61 751 767 I-clinical_variable
( 62 63 768 769 I-clinical_variable
AST 63 66 769 772 I-clinical_variable
) 66 67 772 773 I-clinical_variable
= 68 69 774 775 O
< 69 70 775 776 O
2.5 71 74 777 780 B-upper_bound
Ã— 75 76 781 782 I-upper_bound
ULN 77 80 783 786 I-upper_bound

Any 0 3 787 790 O
serious 4 11 791 798 O
medical 12 19 799 806 B-chronic_disease
or 20 22 807 809 O
psychiatric 23 34 810 821 B-chronic_disease
illness 35 42 822 829 I-chronic_disease
that 43 47 830 834 O
could 48 53 835 840 O
, 53 54 840 841 O
in 55 57 842 844 O
the 58 61 845 848 O
investigator 62 74 849 861 O
's 74 76 861 863 O
opinion 77 84 864 871 O
, 84 85 871 872 O
potentially 86 97 873 884 O
interfere 98 107 885 894 O
with 108 112 895 899 O
the 113 116 900 903 O
completion 117 127 904 914 O
of 128 130 915 917 O
treatment 131 140 918 927 B-treatment
according 141 150 928 937 O
to 151 153 938 940 O
this 154 158 941 945 O
protocol 159 167 946 954 O

Are 0 3 955 958 O
postmenopausal 4 18 959 973 O
for 19 22 974 977 O
at 23 25 978 980 O
least 26 31 981 986 O
1 32 33 987 988 B-lower_bound
year 34 38 989 993 I-lower_bound
before 39 45 994 1000 O
the 46 49 1001 1004 O
screening 50 59 1005 1014 O
visit 60 65 1015 1020 O

Baseline 0 8 1021 1029 O
marrow 9 15 1030 1036 O
burden 16 22 1037 1043 O
or 23 25 1044 1046 O
myeloma 26 33 1047 1054 B-cancer
of 34 36 1055 1057 O
at 37 39 1058 1060 O
least 40 45 1061 1066 O
30 46 48 1067 1069 B-lower_bound
% 48 49 1069 1070 I-lower_bound

Calculated 0 10 1071 1081 B-clinical_variable
creatinine 11 21 1082 1092 I-clinical_variable
clearance 22 31 1093 1102 I-clinical_variable
> 32 33 1103 1104 O
= 33 34 1104 1105 O
30 35 37 1106 1108 B-lower_bound
mL 38 40 1109 1111 I-lower_bound
/ 40 41 1111 1112 I-lower_bound
min 41 44 1112 1115 I-lower_bound

Central 0 7 1116 1123 B-chronic_disease
nervous 8 15 1124 1131 I-chronic_disease
system 16 22 1132 1138 I-chronic_disease
involvement 23 34 1139 1150 I-chronic_disease

Cluster 0 7 1151 1158 O
of 8 10 1159 1161 O
differentiation 11 26 1162 1177 O
( 27 28 1178 1179 B-clinical_variable
CD)4 28 32 1179 1183 I-clinical_variable
+ 32 33 1183 1184 I-clinical_variable
cells 34 39 1185 1190 I-clinical_variable
nadirs 40 46 1191 1197 I-clinical_variable
> 47 48 1198 1199 O
350 49 52 1200 1203 B-lower_bound
/ 52 53 1203 1204 I-lower_bound
mm^3 53 57 1204 1208 I-lower_bound

Definite 0 8 1209 1217 O
development 9 20 1218 1229 O
of 21 23 1230 1232 O
new 24 27 1233 1236 O
bone 28 32 1237 1241 O
lesions 33 40 1242 1249 O
or 41 43 1250 1252 O
extramedullary 44 58 1253 1267 B-cancer
plasmacytomas 59 72 1268 1281 I-cancer
or 73 75 1282 1284 O
definite 76 84 1285 1293 O
increase 85 93 1294 1302 O
in 94 96 1303 1305 O
the 97 100 1306 1309 O
size 101 105 1310 1314 O
of 106 108 1315 1317 O
existing 109 117 1318 1326 O
bone 118 122 1327 1331 O
lesions 123 130 1332 1339 O
or 131 133 1340 1342 O
extramedullary 134 148 1343 1357 O
plasmacytomas 149 162 1358 1371 O

Disease 0 7 1372 1379 O
free 8 12 1380 1384 O
of 13 15 1385 1387 O
prior 16 21 1388 1393 O
malignancies 22 34 1394 1406 B-cancer
for 35 38 1407 1410 O
> 39 40 1411 1412 O
5 41 42 1413 1414 B-lower_bound
years 43 48 1415 1420 I-lower_bound
with 49 53 1421 1425 O
exception 54 63 1426 1435 O
of 64 66 1436 1438 O
patients 67 75 1439 1447 O
with 76 80 1448 1452 O
nonmelanoma 81 92 1453 1464 B-cancer
skin 93 97 1465 1469 I-cancer
cancer 98 104 1470 1476 I-cancer
or 105 107 1477 1479 O
carcinoma 108 117 1480 1489 B-cancer
in 118 120 1490 1492 I-cancer
situ 121 125 1493 1497 I-cancer
of 126 128 1498 1500 O
any 129 132 1501 1504 O
type 133 137 1505 1509 O
are 138 141 1510 1513 O
not 142 145 1514 1517 O
excluded 146 154 1518 1526 O
if 155 157 1527 1529 O
they 158 162 1530 1534 O
have 163 167 1535 1539 O
undergone 168 177 1540 1549 O
complete 178 186 1550 1558 O
resection 187 196 1559 1568 B-treatment

Disease 0 7 1569 1576 O
that 8 12 1577 1581 O
has 13 16 1582 1585 O
progressed 17 27 1586 1596 O
during 28 34 1597 1603 O
or 35 37 1604 1606 O
within 38 44 1607 1613 O
6 45 46 1614 1615 B-upper_bound
months 47 53 1616 1622 I-upper_bound
of 54 56 1623 1625 O
coming 57 63 1626 1632 O
off 64 67 1633 1636 O
therapy 68 75 1637 1644 B-treatment
with 76 80 1645 1649 I-treatment
bortezomib 81 91 1650 1660 I-treatment
and 92 95 1661 1664 I-treatment
lenalidomide 96 108 1665 1677 I-treatment
( 109 110 1678 1679 O
either 110 116 1679 1685 O
sequentially 117 129 1686 1698 O
or 130 132 1699 1701 O
concurrent 133 143 1702 1712 O
) 143 144 1712 1713 O
; 144 145 1713 1714 O
progressive 146 157 1715 1726 O
disease 158 165 1727 1734 O

Eastern 0 7 1735 1742 B-clinical_variable
Cooperative 8 19 1743 1754 I-clinical_variable
Oncology 20 28 1755 1763 I-clinical_variable
Group 29 34 1764 1769 I-clinical_variable
( 35 36 1770 1771 I-clinical_variable
ECOG 36 40 1771 1775 I-clinical_variable
) 40 41 1775 1776 I-clinical_variable
performance 42 53 1777 1788 I-clinical_variable
status 54 60 1789 1795 I-clinical_variable
and/or 61 67 1796 1802 O
other 68 73 1803 1808 O
performance 74 85 1809 1820 O
status 86 92 1821 1827 O
0 93 94 1828 1829 B-lower_bound
, 94 95 1829 1830 O
1 96 97 1831 1832 O
, 97 98 1832 1833 O
or 99 101 1834 1836 O
2 102 103 1837 1838 B-upper_bound

Evidence 0 8 1839 1847 O
of 9 11 1848 1850 O
current 12 19 1851 1858 O
uncontrolled 20 32 1859 1871 O
cardiovascular 33 47 1872 1886 B-chronic_disease
conditions 48 58 1887 1897 I-chronic_disease
, 58 59 1897 1898 O
including 60 69 1899 1908 O
uncontrolled 70 82 1909 1921 B-chronic_disease
hypertension 83 95 1922 1934 I-chronic_disease
, 95 96 1934 1935 O
uncontrolled 97 109 1936 1948 O
cardiac 110 117 1949 1956 O
arrhythmias 118 129 1957 1968 B-chronic_disease
, 129 130 1968 1969 O
symptomatic 131 142 1970 1981 O
congestive 143 153 1982 1992 O
heart 154 159 1993 1998 B-chronic_disease
failure 160 167 1999 2006 I-chronic_disease
, 167 168 2006 2007 O
unstable 169 177 2008 2016 B-chronic_disease
angina 178 184 2017 2023 I-chronic_disease
, 184 185 2023 2024 O
or 186 188 2025 2027 O
myocardial 189 199 2028 2038 B-chronic_disease
infarction 200 210 2039 2049 I-chronic_disease
within 211 217 2050 2056 O
the 218 221 2057 2060 O
past 222 226 2061 2065 B-upper_bound
6 227 228 2066 2067 I-upper_bound
months 229 235 2068 2074 I-upper_bound

Failure 0 7 2075 2082 O
to 8 10 2083 2085 O
have 11 15 2086 2090 O
fully 16 21 2091 2096 O
recovered 22 31 2097 2106 O
( 32 33 2107 2108 O
i.e. 33 37 2108 2112 O
, 37 38 2112 2113 O
= 39 40 2114 2115 O
< 40 41 2115 2116 O
grade 42 47 2117 2122 B-upper_bound
1 48 49 2123 2124 I-upper_bound
toxicity 50 58 2125 2133 B-clinical_variable
or 59 61 2134 2136 O
to 62 64 2137 2139 O
patient 65 72 2140 2147 O
's 72 74 2147 2149 O
clinical 75 83 2150 2158 B-clinical_variable
baseline 84 92 2159 2167 I-clinical_variable
) 92 93 2167 2168 O
from 94 98 2169 2173 O
the 99 102 2174 2177 O
reversible 103 113 2178 2188 O
effects 114 121 2189 2196 O
of 122 124 2197 2199 O
prior 125 130 2200 2205 B-treatment
chemotherapy 131 143 2206 2218 I-treatment

Female 0 6 2219 2225 B-gender
patients 7 15 2226 2234 I-gender
who 16 19 2235 2238 O
are 20 23 2239 2242 O
lactating 24 33 2243 2252 O
or 34 36 2253 2255 O
have 37 41 2256 2260 O
a 42 43 2261 2262 O
positive 44 52 2263 2271 B-pregnancy
serum 53 58 2272 2277 I-pregnancy
pregnancy 59 68 2278 2287 I-pregnancy
test 69 73 2288 2292 O
during 74 80 2293 2299 O
the 81 84 2300 2303 O
screening 85 94 2304 2313 O
period 95 101 2314 2320 O

For 0 3 2321 2324 O
patients 4 12 2325 2333 O
without 13 20 2334 2341 O
a 21 22 2342 2343 O
measurable 23 33 2344 2354 O
serum 34 39 2355 2360 O
or 40 42 2361 2363 O
urine 43 48 2364 2369 O
M 49 50 2370 2371 O
- 50 51 2371 2372 O
component 51 60 2372 2381 O
or 61 63 2382 2384 O
serum 64 69 2385 2390 O
free 70 74 2391 2395 O
light 75 80 2396 2401 O
chain 81 86 2402 2407 O
level 87 92 2408 2413 O
: 92 93 2413 2414 O
% 94 95 2415 2416 B-clinical_variable
marrow 96 102 2417 2423 I-clinical_variable
involvement 103 114 2424 2435 I-clinical_variable
with 115 119 2436 2440 O
myeloma 120 127 2441 2448 B-cancer
( 128 129 2449 2450 O
absolute 129 137 2450 2458 O
increase 138 146 2459 2467 O
must 147 151 2468 2472 O
be 152 154 2473 2475 O
> 155 156 2476 2477 O
= 156 157 2477 2478 O
10 158 160 2479 2481 B-lower_bound
% 160 161 2481 2482 I-lower_bound
) 161 162 2482 2483 O

For 0 3 2484 2487 O
patients 4 12 2488 2496 O
without 13 20 2497 2504 O
a 21 22 2505 2506 O
measurable 23 33 2507 2517 O
serum 34 39 2518 2523 O
or 40 42 2524 2526 O
urine 43 48 2527 2532 O
M 49 50 2533 2534 O
- 50 51 2534 2535 O
protein 51 58 2535 2542 O
but 59 62 2543 2546 O
measurable 63 73 2547 2557 O
disease 74 81 2558 2565 O
by 82 84 2566 2568 O
serum 85 90 2569 2574 B-treatment
free 91 95 2575 2579 I-treatment
light 96 101 2580 2585 I-treatment
chain 102 107 2586 2591 I-treatment
testing 108 115 2592 2599 I-treatment
: 115 116 2599 2600 O
Difference 117 127 2601 2611 O
between 128 135 2612 2619 O
the 136 139 2620 2623 O
involved 140 148 2624 2632 O
and 149 152 2633 2636 O
uninvolved 153 163 2637 2647 O
serum 164 169 2648 2653 O
free 170 174 2654 2658 O
light 175 180 2659 2664 O
chain 181 186 2665 2670 O
level 187 192 2671 2676 O
( 193 194 2677 2678 O
absolute 194 202 2678 2686 B-clinical_variable
increase 203 211 2687 2695 I-clinical_variable
must 212 216 2696 2700 O
be 217 219 2701 2703 O
> 220 221 2704 2705 O
= 221 222 2705 2706 O
10 223 225 2707 2709 B-lower_bound
mg 226 228 2710 2712 I-lower_bound
/ 228 229 2712 2713 I-lower_bound
dL 229 231 2713 2715 I-lower_bound
) 231 232 2715 2716 O

Hypercalcemia 0 13 2717 2730 B-chronic_disease
( 14 15 2731 2732 O
corrected 15 24 2732 2741 B-clinical_variable
serum 25 30 2742 2747 I-clinical_variable
calcium 31 38 2748 2755 I-clinical_variable
> 39 40 2756 2757 O
11.5 41 45 2758 2762 B-lower_bound
mg 46 48 2763 2765 I-lower_bound
/ 48 49 2765 2766 I-lower_bound
dL 49 51 2766 2768 I-lower_bound
) 51 52 2768 2769 O
attributable 53 65 2770 2782 O
to 66 68 2783 2785 O
myeloma 69 76 2786 2793 B-cancer
( 77 78 2794 2795 O
e.g. 78 82 2795 2799 O
not 83 86 2800 2803 O
due 87 90 2804 2807 O
to 91 93 2808 2810 O
omitted 94 101 2811 2818 O
doses 102 107 2819 2824 O
of 108 110 2825 2827 O
bisphosphonate 111 125 2828 2842 B-treatment
) 125 126 2842 2843 O

Infection 0 9 2844 2853 B-chronic_disease
requiring 10 19 2854 2863 O
systemic 20 28 2864 2872 B-treatment
antibiotic 29 39 2873 2883 I-treatment
therapy 40 47 2884 2891 I-treatment
or 48 50 2892 2894 O
other 51 56 2895 2900 O
serious 57 64 2901 2908 O
infection 65 74 2909 2918 B-chronic_disease
within 75 81 2919 2925 O
14 82 84 2926 2928 B-upper_bound
days 85 89 2929 2933 I-upper_bound
before 90 96 2934 2940 I-upper_bound
study 97 102 2941 2946 O
enrollment 103 113 2947 2957 O

Involved 0 8 2958 2966 O
serum 9 14 2967 2972 B-clinical_variable
free 15 19 2973 2977 I-clinical_variable
light 20 25 2978 2983 I-clinical_variable
chain 26 31 2984 2989 I-clinical_variable
> 32 33 2990 2991 O
= 33 34 2991 2992 O
10 35 37 2993 2995 B-lower_bound
mg 38 40 2996 2998 I-lower_bound
/ 40 41 2998 2999 I-lower_bound
dL 41 43 2999 3001 I-lower_bound
( 44 45 3002 3003 O
> 45 46 3003 3004 O
= 46 47 3004 3005 O
100 48 51 3006 3009 B-lower_bound
mg 52 54 3010 3012 I-lower_bound
/ 54 55 3012 3013 I-lower_bound
L 55 56 3013 3014 I-lower_bound
) 56 57 3014 3015 O
AND 58 61 3016 3019 O
an 62 64 3020 3022 O
abnormal 65 73 3023 3031 O
serum 74 79 3032 3037 O
free 80 84 3038 3042 O
light 85 90 3043 3048 O
chain 91 96 3049 3054 O
ratio 97 102 3055 3060 O

Known 0 5 3061 3066 O
allergy 6 13 3067 3074 O
to 14 16 3075 3077 O
any 17 20 3078 3081 O
of 21 23 3082 3084 O
the 24 27 3085 3088 O
study 28 33 3089 3094 B-treatment
medications 34 45 3095 3106 I-treatment
, 45 46 3106 3107 O
their 47 52 3108 3113 O
analogues 53 62 3114 3123 O
, 62 63 3123 3124 O
or 64 66 3125 3127 O
excipients 67 77 3128 3138 O
in 78 80 3139 3141 O
the 81 84 3142 3145 O
various 85 92 3146 3153 O
formulations 93 105 3154 3166 O
of 106 108 3167 3169 O
any 109 112 3170 3173 O
agent 113 118 3174 3179 O

Known 0 5 3180 3185 O
gastrointestinal 6 22 3186 3202 B-chronic_disease
( 23 24 3203 3204 I-chronic_disease
GI 24 26 3204 3206 I-chronic_disease
) 26 27 3206 3207 I-chronic_disease
disease 28 35 3208 3215 I-chronic_disease
or 36 38 3216 3218 O
GI 39 41 3219 3221 B-treatment
procedure 42 51 3222 3231 I-treatment
that 52 56 3232 3236 O
could 57 62 3237 3242 O
interfere 63 72 3243 3252 O
with 73 77 3253 3257 O
the 78 81 3258 3261 O
oral 82 86 3262 3266 B-treatment
absorption 87 97 3267 3277 I-treatment
or 98 100 3278 3280 O
tolerance 101 110 3281 3290 O
of 111 113 3291 3293 O
study 114 119 3294 3299 B-treatment
drugs 120 125 3300 3305 I-treatment
including 126 135 3306 3315 O
difficulty 136 146 3316 3326 O
swallowing 147 157 3327 3337 O

Known 0 5 3338 3343 O
ongoing 6 13 3344 3351 O
or 14 16 3352 3354 O
active 17 23 3355 3361 B-chronic_disease
systemic 24 32 3362 3370 I-chronic_disease
infection 33 42 3371 3380 I-chronic_disease
, 42 43 3380 3381 O
active 44 50 3382 3388 O
hepatitis 51 60 3389 3398 B-chronic_disease
B 61 62 3399 3400 I-chronic_disease
or 63 65 3401 3403 I-chronic_disease
C 66 67 3404 3405 I-chronic_disease
virus 68 73 3406 3411 I-chronic_disease
infection 74 83 3412 3421 I-chronic_disease

Life 0 4 3422 3426 B-clinical_variable
expectancy 5 15 3427 3437 I-clinical_variable
of 16 18 3438 3440 O
greater 19 26 3441 3448 O
than 27 31 3449 3453 O
3 32 33 3454 3455 B-lower_bound
months 34 40 3456 3462 I-lower_bound

Major 0 5 3463 3468 B-treatment
surgery 6 13 3469 3476 I-treatment
within 14 20 3477 3483 O
14 21 23 3484 3486 B-upper_bound
days 24 28 3487 3491 I-upper_bound
before 29 35 3492 3498 I-upper_bound
enrollment 36 46 3499 3509 O

No 0 2 3510 3512 O
history 3 10 3513 3520 O
of 11 13 3521 3523 O
acquired 14 22 3524 3532 B-chronic_disease
immunodeficiency 23 39 3533 3549 I-chronic_disease
syndrome 40 48 3550 3558 I-chronic_disease
( 49 50 3559 3560 I-chronic_disease
AIDS)-defining 50 64 3560 3574 I-chronic_disease
conditions 65 75 3575 3585 O
or 76 78 3586 3588 O
other 79 84 3589 3594 O
HIV 85 88 3595 3598 B-chronic_disease
related 89 96 3599 3606 O
illness 97 104 3607 3614 O

Patient 0 7 3615 3622 O
has 8 11 3623 3626 O
> 12 13 3627 3628 O
= 13 14 3628 3629 O
grade 15 20 3630 3635 B-lower_bound
3 21 22 3636 3637 I-lower_bound
peripheral 23 33 3638 3648 B-clinical_variable
neuropathy 34 44 3649 3659 I-clinical_variable
, 44 45 3659 3660 O
or 46 48 3661 3663 O
grade 49 54 3664 3669 B-lower_bound
2 55 56 3670 3671 I-lower_bound
with 57 61 3672 3676 O
pain 62 66 3677 3681 O
on 67 69 3682 3684 O
clinical 70 78 3685 3693 O
examination 79 90 3694 3705 O
during 91 97 3706 3712 O
the 98 101 3713 3716 O
screening 102 111 3717 3726 O
period 112 118 3727 3733 O

Patients 0 8 3734 3742 O
must 9 13 3743 3747 O
have 14 18 3748 3752 O
a 19 20 3753 3754 O
confirmed 21 30 3755 3764 O
biopsy 31 37 3765 3771 B-treatment
diagnosis 38 47 3772 3781 O
of 48 50 3782 3784 O
a 51 52 3785 3786 O
multiple 53 61 3787 3795 B-cancer
myeloma 62 69 3796 3803 I-cancer

Patients 0 8 3804 3812 O
must 9 13 3813 3817 O
have 14 18 3818 3822 O
measurable 19 29 3823 3833 B-chronic_disease
disease 30 37 3834 3841 I-chronic_disease
according 38 47 3842 3851 O
to 48 50 3852 3854 O
International 51 64 3855 3868 O
Myeloma 65 72 3869 3876 O
Working 73 80 3877 3884 O
Group 81 86 3885 3890 O
( 87 88 3891 3892 O
IMWG 88 92 3892 3896 O
) 92 93 3896 3897 O
criteria 94 102 3898 3906 O

Platelet 0 8 3907 3915 B-clinical_variable
count 9 14 3916 3921 I-clinical_variable
> 15 16 3922 3923 O
= 16 17 3923 3924 O
50,000 18 24 3925 3931 B-lower_bound
/ 24 25 3931 3932 I-lower_bound
mm^3 25 29 3932 3936 I-lower_bound
; 29 30 3936 3937 O
note 31 35 3938 3942 O
: 35 36 3942 3943 O
platelet 37 45 3944 3952 O
transfusions 46 58 3953 3965 O
to 59 61 3966 3968 O
help 62 66 3969 3973 O
patients 67 75 3974 3982 O
meet 76 80 3983 3987 O
eligibility 81 92 3988 3999 O
criteria 93 101 4000 4008 O
are 102 105 4009 4012 O
not 106 109 4013 4016 O
allowed 110 117 4017 4024 O
within 118 124 4025 4031 O
3 125 126 4032 4033 B-upper_bound
days 127 131 4034 4038 I-upper_bound
before 132 138 4039 4045 I-upper_bound
study 139 144 4046 4051 O
enrollment 145 155 4052 4062 O

Previous 0 8 4063 4071 O
allergic 9 17 4072 4080 O
reaction 18 26 4081 4089 O
to 27 29 4090 4092 O
an 30 32 4093 4095 O
immunomodulatory 33 49 4096 4112 B-allergy_name
drug 50 54 4113 4117 I-allergy_name
( 55 56 4118 4119 I-allergy_name
IMiD 56 60 4119 4123 I-allergy_name
) 60 61 4123 4124 I-allergy_name

Previous 0 8 4125 4133 B-treatment
treatment 9 18 4134 4143 I-treatment
with 19 23 4144 4148 I-treatment
ixazomib 24 32 4149 4157 I-treatment
or 33 35 4158 4160 O
pomalidomide 36 48 4161 4173 B-treatment

Radiotherapy 0 12 4174 4186 B-treatment
within 13 19 4187 4193 O
14 20 22 4194 4196 B-upper_bound
days 23 27 4197 4201 I-upper_bound
before 28 34 4202 4208 I-upper_bound
enrollment 35 45 4209 4219 O

Serum 0 5 4220 4225 B-clinical_variable
M 6 7 4226 4227 I-clinical_variable
- 7 8 4227 4228 I-clinical_variable
protein 8 15 4228 4235 I-clinical_variable
( 16 17 4236 4237 O
absolute 17 25 4237 4245 O
increase 26 34 4246 4254 O
must 35 39 4255 4259 O
be 40 42 4260 4262 O
> 43 44 4263 4264 O
= 44 45 4264 4265 O
0.5 46 49 4266 4269 B-lower_bound
g 50 51 4270 4271 I-lower_bound
/ 51 52 4271 4272 I-lower_bound
dL 52 54 4272 4274 I-lower_bound
) 54 55 4274 4275 O

Serum 0 5 4276 4281 B-clinical_variable
M 6 7 4282 4283 I-clinical_variable
- 7 8 4283 4284 I-clinical_variable
protein 8 15 4284 4291 I-clinical_variable
> 16 17 4292 4293 O
= 17 18 4293 4294 O
1.0 19 22 4295 4298 B-lower_bound
g 23 24 4299 4300 I-lower_bound
/ 24 25 4300 4301 I-lower_bound
dL 25 27 4301 4303 I-lower_bound

Strong 0 6 4304 4310 B-treatment
inhibitors 7 17 4311 4321 I-treatment
of 18 20 4322 4324 I-treatment
cytochrome 21 31 4325 4335 I-treatment
P450 32 36 4336 4340 I-treatment
, 36 37 4340 4341 O
family 38 44 4342 4348 O
1 45 46 4349 4350 O
, 46 47 4350 4351 O
subfamily 48 57 4352 4361 O
A 58 59 4362 4363 O
, 59 60 4363 4364 O
polypeptide 61 72 4365 4376 B-treatment
2 73 74 4377 4378 I-treatment
( 75 76 4379 4380 I-treatment
CYP1A2 76 82 4380 4386 I-treatment
) 82 83 4386 4387 I-treatment

Strong 0 6 4388 4394 O
inhibitors 7 17 4395 4405 O
of 18 20 4406 4408 O
family 21 27 4409 4415 O
cytochrome 28 38 4416 4426 B-treatment
P450 39 43 4427 4431 I-treatment
family 44 50 4432 4438 I-treatment
3 51 52 4439 4440 I-treatment
, 52 53 4440 4441 O
subfamily 54 63 4442 4451 B-treatment
A 64 65 4452 4453 I-treatment
( 66 67 4454 4455 I-treatment
3A 67 69 4455 4457 I-treatment
) 69 70 4457 4458 I-treatment

Total 0 5 4459 4464 B-clinical_variable
bilirubin 6 15 4465 4474 I-clinical_variable
= 16 17 4475 4476 O
< 17 18 4476 4477 O
2.0 19 22 4478 4481 B-upper_bound
Ã— 23 24 4482 4483 I-upper_bound
the 25 28 4484 4487 I-upper_bound
upper 29 34 4488 4493 I-upper_bound
limit 35 40 4494 4499 I-upper_bound
of 41 43 4500 4502 I-upper_bound
the 44 47 4503 4506 I-upper_bound
normal 48 54 4507 4513 I-upper_bound
range 55 60 4514 4519 I-upper_bound
( 61 62 4520 4521 I-upper_bound
ULN 62 65 4521 4524 I-upper_bound
) 65 66 4524 4525 I-upper_bound

Treatment 0 9 4526 4535 B-treatment
sensitive 10 19 4536 4545 O
HIV 20 23 4546 4549 B-chronic_disease
and 24 27 4550 4553 O
, 27 28 4553 4554 O
if 29 31 4555 4557 O
on 32 34 4558 4560 O
anti 35 39 4561 4565 B-treatment
- 39 40 4565 4566 I-treatment
HIV 40 43 4566 4569 I-treatment
therapy 44 51 4570 4577 I-treatment
, 51 52 4577 4578 O
HIV 53 56 4579 4582 O
viral 57 62 4583 4588 O
load 63 67 4589 4593 O
< 68 69 4594 4595 O
50 70 72 4596 4598 B-upper_bound
copies 73 79 4599 4605 I-upper_bound
/ 79 80 4605 4606 I-upper_bound
mm^3 80 84 4606 4610 I-upper_bound

Treatment 0 9 4611 4620 B-treatment
with 10 14 4621 4625 I-treatment
clarithromycin 15 29 4626 4640 I-treatment
, 29 30 4640 4641 O
anti 31 35 4642 4646 B-treatment
- 35 36 4646 4647 I-treatment
myeloma 36 43 4647 4654 I-treatment
therapy 44 51 4655 4662 I-treatment
including 52 61 4663 4672 O
investigational 62 77 4673 4688 B-treatment
agents 78 84 4689 4695 I-treatment
or 85 87 4696 4698 O
plasmapheresis 88 102 4699 4713 B-treatment
within 103 109 4714 4720 O
30 110 112 4721 4723 B-upper_bound
days 113 117 4724 4728 I-upper_bound
prior 118 123 4729 4734 I-upper_bound
to 124 126 4735 4737 O
treatment 127 136 4738 4747 B-treatment
in 137 139 4748 4750 O
this 140 144 4751 4755 O
study 145 150 4756 4761 O

Urine 0 5 4762 4767 B-clinical_variable
M 6 7 4768 4769 I-clinical_variable
- 7 8 4769 4770 I-clinical_variable
protein 8 15 4770 4777 I-clinical_variable
( 16 17 4778 4779 O
absolute 17 25 4779 4787 O
increase 26 34 4788 4796 O
must 35 39 4797 4801 O
be 40 42 4802 4804 O
> 43 44 4805 4806 O
= 44 45 4806 4807 O
200 46 49 4808 4811 B-lower_bound
mg/24 50 55 4812 4817 I-lower_bound
hours 56 61 4818 4823 I-lower_bound
) 61 62 4823 4824 O

Urine 0 5 4825 4830 B-clinical_variable
M 6 7 4831 4832 I-clinical_variable
- 7 8 4832 4833 I-clinical_variable
protein 8 15 4833 4840 I-clinical_variable
> 16 17 4841 4842 O
= 17 18 4842 4843 O
200 19 22 4844 4847 B-lower_bound
mg/24 23 28 4848 4853 I-lower_bound
hours 29 34 4854 4859 I-lower_bound

